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Abstract
Herein, we report two extremely rare cases of differentiated thyroid carcinoma (DTC) with
extended tumor thrombus or mediastinum lymph node metastasis (LNM) involving the superior
vena cava (SVC), causing SVC syndrome. Both of these patients were successfully treated with
radical resection and reconstruction of the SVC using autologous tissue instead of an expanded
polytetrafluoroethylene (ePTFE) graft. The left brachiocephalic vein was used to reconstruct the
SVC in a papillary thyroid carcinoma patient with mediastinum LNM and a pericardial patch was
used in a follicular thyroid carcinoma patient with tumor thrombus. Our search of the English-
language literature found sporadic reports of SVC resection with reconstruction by vascular graft
(ePTFE), interposed between the brachiocephalic vein and the right atrium. However, SVC
reconstruction using autologous tissue in thyroid carcinoma has not been reported to date. To our
knowledge, this is the first report describing such an unusual technique in DTC patients.
Background
Superior vena cava (SVC) syndrome is extremely rare in
patients with differentiated thyroid carcinoma (DTC).
Direct primary tumor invasion (T4b tumor in the 6th TNM
classification), huge mediastinum lymph node metastasis
(LNM), or extended tumor thrombus can be causes of
such exceptionally unusual manifestations [1-9]. SVC syn-
drome leads to various clinical symptoms, such as head-
ache, facial flush and swelling, and varicose veins over the
upper body surface, finally resulting in lethal outcomes if
appropriate treatment is not administered [1,4,9-11]. In
particular, tumor thrombus in the great vein can also be a
cause of sudden death due to pulmonary embolism. In
the past, such advanced DTCs were usually treated with
palliative management because of the difficulty of the sur-
gical approach. Thus, surgery for SVC syndrome has been
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exceptionally challenging in only selected patients [7,12].
Recently, aggressive surgery has been performed occasion-
ally to relieve SVC syndrome. Our search of the English-
language literature found only sporadic reports of SVC
resection and reconstruction with an expanded poly-
tetrafluoroethylene (ePTFE) graft [2,3,8]. However, there
are some concerns about the potential for vascular graft
obstruction [8,13,14]. Our two patients were treated suc-
cessfully with radical resection and reconstruction using
autologous tissue, the left brachiocephalic vein or a peri-
cardial patch, to reconstruct the interposition between the
right brachiocephalic vein and the SVC. To our knowl-
edge, this is the first report describing SVC reconstruction
with autologous tissue to treat SVC syndrome in advanced
DTC patients.
Case presentation
Case 1
A 74-year-old woman was referred to our institution for
treatment of neck and mediastinum lymph node recur-
rence involving SVC. The patient initially underwent total
thyroidectomy with bilateral modified neck dissection
(MND) for primary papillary thyroid carcinoma (PTC)
with cervical lymphadenopathy at another institution
three years before our surgery. On our physical examina-
tion, only the cervical nodes were palpable. Computed
tomography (CT) scan showed critical stenosis of the SVC
due to the recurrent mediastinum LNM (Fig. 1A). This
patient also presented with an elevated serum thyroglob-
ulin (Tg) (707 ng/ml) without thyroglobulin antibody
(TgAb) under TSH suppression (0.025 μIU/ml). Since the
clinical symptoms from near total occlusion of SVC
increased progressively, we subsequently performed radi-
A: Enhanced computed tomography (CT) reveals stenosis of the superior vena cava (SVC) due to invasion of the mediastinum  lymph node metastasis (LNM) Figure 1
A: Enhanced computed tomography (CT) reveals stenosis of the superior vena cava (SVC) due to invasion of 
the mediastinum lymph node metastasis (LNM). B: Postoperative CT scan shows the patency of the venous pathway 
after resection and reconstruction with the autograft (left brachiocephalic vein). Two arrows indicate the sites of distal and 
proximal anastomosis.World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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cal resection to remove the recurrent mediastinum LNM
and prevent further progression of SVC syndrome. Ini-
tially, we attempted to dissect only the mediastinum LNM
with preservation of the great veins but could not remove
such advanced lesions because of fixed invasion to the
right brachiocephalic vein and SVC (Fig. 2A). Therefore,
we subsequently attempted to perform radical resection
followed by venous reconstruction. Temporary bypass
using an ePTFE graft was placed between the distal site of
the left brachiocephalic vein and the right auricle after
resection of the left brachiocephalic vein (Fig. 2B). The left
brachiocephalic vein was not involved macroscopically.
After confirmation of the stable condition of the venous
pathway under temporary bypass, the recurrent mediasti-
num LNM, right brachiocephalic vein and SVC were
simultaneously resected. Intraluminal venous invasion of
the mediastinum LNM was seen in the opened SVC (Fig.
2C). Next, vascular reconstruction was performed with the
use of the already resected left brachiocephalic vein as
autologous tissue (Fig. 2D). This autograft was placed
between the distal site of the right brachiocephalic vein
and the proximal site of the SVC. Finally, the ePTFE graft
was removed after establishment of revascularization by
autograft (Fig. 2E). There were no significant complica-
tions after this surgery.
Postoperative CT scan revealed that the reconstructed
venous system was functioning well (Fig. 1B). His-
topathological examination confirmed that the resected
specimens were metastases from PTC and no portions of
undifferentiated carcinoma were found.
A: Mediastinum LNM invading the posterolateral wall of right brachiocephalic vein and superior vena cava (SVC) Figure 2
A: Mediastinum LNM invading the posterolateral wall of right brachiocephalic vein and superior vena cava 
(SVC). B: Temporary bypass using an expanded polytetrafluoroethylene (ePTFE) graft was placed between left subclavian vein 
and right auricle after resection of the left brachiocephalic vein, which was not involved. C: Intraluminal invasion of mediasti-
num LNM in opened SVC. D: The right brachiocephalic vein and SVC were resected for complete removal of the invasive 
mediastinum LNM. The isolated left brachiocephalic vein was interposed to reconstruct the venous pathway between the right 
brachiocephalic vein and the SVC. E: Finally, the ePTFE graft as a temporary bypass was removed after confirmation of the flow 
in the reconstructed venous pathway.World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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Unfortunately, lung metastasis with pleural effusion
occurred 13 months later. We could not provide any addi-
tional effective treatments to alleviate the symptoms. Her
general condition gradually became worse and then she
consequently died of disease 19 months after our surgery.
Our surgical intervention was considered to contribute to
preventing the development of SVC syndrome or immedi-
ate death by tumor embolism.
Case 2
A 64-year-old man was referred to our institution for the
treatment of SVC syndrome caused by extended tumor
thrombus from a follicular thyroid carcinoma (FTC). The
patient initially underwent total thyroidectomy with ipsi-
lateral MND for primary FTC with cervical lymphadenop-
athy at another institution. This patient initially presented
with tumor thrombus in the left internal jugular vein via
the brachiocephalic vein to the upper part of the SVC.
However, only the left internal jugular vein was simulta-
neously resected and the extended tumor thrombus in the
left brachiocephalic vein and SVC was not removed dur-
ing the initial surgery. Three months later, the patient
complained of facial flushing and hypervascularity by var-
icose veins over the upper body surface, suggesting the
occurrence of SVC syndrome. RI therapy was planned,
however the clinical symptoms became worse during the
preparation (levothyroxine withdrawal) for RI therapy.
Therefore the preparation was discontinued and levothy-
roxine was again administered. The patient was subse-
quently referred to our institution an additional three
months later (i.e., six months after the initial surgery) and
additionally presented with right arm swelling and edema
as clinical manifestations, suggesting progression of the
SVC syndrome. No local or regional lesions were palpable
on physical examination. Preoperative CT scan showed
extended tumor thrombus totally occupying the left bra-
chiocephalic vein and SVC (Fig. 3A). The patient had an
elevated serum Tg (25000 ng/ml) without TgAb under
TSH suppression (0.039 μIU/ml). Thus, the tumor throm-
bus that persisted after the initial surgery led to the pro-
gressive development of SVC syndrome.
We immediately performed radical resection and recon-
struction to entirely relieve the SVC syndrome. In our sur-
gical procedure, the extended tumor thrombus was
successfully removed through resection of the right and
A: Extended tumor thrombus totally occupying in the left brachiocephalic vein and the SVC was evident Figure 3
A: Extended tumor thrombus totally occupying in the left brachiocephalic vein and the SVC was evident. B: 
Successfully reconstructed venous pathway.World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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left brachiocephalic veins and the SVC (Fig. 4A, 4B).
Indeed, isolated thrombectomy was not possible because
of tumor adhesion and invasion to the anterior intralumi-
nal wall of the great veins; however a part of the posterior
wall of these veins could be preserved somewhat (Fig.
4C). An autologous pericardial patch was then used to
reconstruct the venous pathway between both the brachi-
ocephalic veins and the right atrium (Fig. 4D). Macro-
scopic findings of the resected tumor thrombus and veins
are shown in Fig. 4E. Clinically, the SVC syndrome
improved immediately after our surgery. Postoperative CT
scan showed that revascularization was successfully
achieved with the reconstructed venous system (Fig. 3B).
Histopathological examination and subsequent immuno-
histochemical analysis revealed positive staining for Tg in
the cells from the tumor thrombus, confirming that the
resected specimens were angio-invasion from the FTC.
After the surgery, RI ablation could be safely performed
and TSH suppression is currently being maintained with
an appropriate dose of levothyroxine. There has been no
A: Extended tumor thrombus in the left brachiocephalic vein and the SVC was apparent Figure 4
A: Extended tumor thrombus in the left brachiocephalic vein and the SVC was apparent. B: Tumor thrombus was 
macroscopically observed in the opened great veins. C: Thrombectomy alone was not possible because of the adhesion and 
invasion to the anterior intraluminal wall of the great veins; however a part of the posterior wall of these veins was able to be 
preserved. D: Pericardial patch was used to reconstruct the venous pathway between both brachiocephalic veins and the right 
atrium. E: Macroscopic finding of the resected tumor thrombus.World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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disease progression during the eight months of follow-up
since our surgical treatments.
Review of the literature
Table 1 summarizes the previous reports that describe the
treatments and outcomes in DTC patients who exhibited
extended tumor thrombus in the mediastinum great
veins. The prognoses in such cases were principally unsat-
isfactory. However some treatments were effective in
improving the progression of SVC syndrome and clinical
outcomes. Thrombectomy was considered the most valu-
able surgical procedure when it was feasible. Our report is
the first to use autologous graft as an alternative to the
ePTFE graft that has generally been used for SVC recon-
struction in DTC patients.
Discussion
Since SVC syndrome caused by a mediastinum tumor
from thyroid carcinoma is particularly rare, surgical inter-
vention has been considered problematic and its indica-
tion remains controversial. Tumor thrombus within the
SVC can be a cause of critical syndrome followed by lethal
outcomes [1,4,7,10,11]. In the management of thyroid
carcinoma, Thompson et al. firstly reported a case with
Table 1: Tumor thrombus from differentiated thyroid caricnomas in the mediastinum great veins.
Authors Patients Pathology Location Therapy Outcomes
Kim et al. [1] 1966 64M FTC IJV to RA No surgery Death 18 days
Thompson et al. [7] 1978 67F FTC IJV to RA Thrombectomy Alive 24 months
Perez et al. [12] 1984 48F FTC IJV to SVC Thrombectomy Alive 4 months
Niderle et al. [8] 1990 57M FTC IJV to RA Thrombectomy Alive 13 months
79F FTC IJV to RA Thrombectomy Alive 50 months
53F FTC IJV to RA Reconstruction (ePTFE graft) Thrombectomy Death 8 months
Patel et al. [4] 1997 79F PTC IJV to SVC, PV Thrombectomy Death 12 days
Onaran et al. [11] 1998 48M Hürthle IJV to SVC No surgery (biopsy), RI therapy Death 12 months
Wiseman et al. [10] 2000 84M DTC? IJV to SVC Thrombectomy Death 12 months
Koike et al. [16] 2002 26F PTC BCV to SVC Cardiopulmonary bypass Alive 8 months
Hasegawa et al. [15] 2002 78F PTC IJV to RA Reconstruction (ePTFE graft) Death 36 days
Motohashi et al. [3] 2005 64F PTC IJV to SVC Reconsrtuction (ePTFE graft) Alive 24 months
Sugimoto et al. [2] 2006 61M PTC BCV to RA Thrombectomy, RI therapy Death 12 days
Taib et al. [6] 2007 66F FTC IJV to RA Thrombectomy, RI therapy Alive 18 months
62F FTC IJV to RA Thrombectomy Alive 18 months
45F FTC IJV to BCV Thrombectomy Death 21 days
Yamagami et al. [17] 2008 74M PTC IJV to RA No surgery, RI therapy, EBRT Alive 7 months
Hyer et al. [5] 2008 81F FTC IJV to SVC Reconsrtuction (pericardial patch) Alive 66 months
Wada et al. [present] - 64M FTC IJV to SVC No surgery Alive 7 months
PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma, ATC: anaplastic thyroid carcinoma, DTC: differentiated thyroid carcinoma, IJV: 
internal jugular vein, BCV: brachiocephalic vein, RA: right atrium, ePTFE: extended polytetrafluoroethylene (Gore-Tex) graft, RI: radioactive iodine, 
EBRT: external beam radiotherapy.World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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successful resection of extended tumor thrombus in medi-
astinum great veins [7]. Perez et al. also reported a second
case of successful resection of intraluminal SVC invasion
[12]. Thus, the surgical approach to improve SVC syn-
drome has been challenged and SVC reconstruction has
usually been performed with an ePTFE graft, interposed
between the internal jugular vein and the right atrium, to
reconstruct the venous pathway [2,3,8]. We performed
SVC resection and reconstruction using autologous tissue
without the use of an artificial vascular graft.
In general, patients with SVC syndrome die of disease
when surgical intervention is not applied. Patel et al. and
Wiseman et al. reported poor prognoses in patients with-
out surgery [4,10]. Onaran et al. concluded that appropri-
ate initial surgery might result in a disease-free state
despite the residual presence of the tumor thrombus [11].
Niederle et al. reported three patients with SVC syndrome
caused by tumor thrombus [8]. One patient underwent
SVC reconstruction with an ePTFE graft, which was unfor-
tunately occluded three months later, and another two
patients were clinically asymptomatic after surgical treat-
ment. Thus, aggressive surgery may be useful to relieve
SVC syndrome and to prevent sudden death due to tumor
embolism. Meanwhile, Hasegawa et al. reported immedi-
ate occurrence of intrapulmonary spread of the tumor
after surgery with cardiopulmonary bypass, resulting in
perioperative mortality due to respiratory failure [15].
Thus, surgical intervention for SVC syndrome remains
controversial because of the treatment dilemma between
perioperative morbidity and mortality with aggressive sur-
gery and the poor prognosis with palliative therapy.
ePTFE graft has been used to improve SVC stenosis or
occlusion and provide long relief from SVC syndrome
[2,3]. Sugimoto et al. and Motohashi et al. recommended
reconstruction of the SVC using an artificial graft as the
treatment of choice [2,3]. However, there are some con-
cerns about poor long-term patency of this artificial graft.
Occlusion of the vascular graft has occasionally been
reported during the follow up period [8,13,14]. Shintani
et al. reported poor long-term patency of an ePTFE graft to
reconstruct the left brachiocephalic vein [14]. They prefer-
ably advocate isolated reconstruction of the right brachio-
cephalic vein. The use of Y grafts was not recommended
because of the frequent occlusion of such grafts. Alimi et
al. indicated that close observation of the artificial graft is
essential to determine the potential for graft problems ear-
lier, especially during the first year after reconstruction
[13].
A tumor thrombus can sometimes be relatively easily
removed by thrombectomy alone without simultaneous
resection of the great veins. Koike et al. reported a young
woman with PTC who was successfully treated with
thrombectomy from the brachiocephalic vein [16].
Yamagami et al. also reported a very rare case presenting
with huge tumor thrombus extending to the atrium that
was effectively treated with tumor thrombectomy alone,
without harvesting all of the associated great veins [17].
Some authors have suggested that positive ring sign, a thin
rim of contrast medium surrounding the tumor thrombus
on enhanced CT examination, indicates the feasibility of
successful tumor thrombectomy [6]. This sign may be use-
ful to make a decision regarding the surgical strategy.
Unfortunately, our case with extended tumor thrombus
did not show this sign and thrombectomy alone was con-
sidered impossible because of the fixed adhesion and
invasion of the tumor to the intraluminal wall of the great
veins.
In our cases, we used autologous tissue, the brachio-
cephalic veins or a pericardial patch, to reconstruct the
venous pathway. In fact, similar technique with autolo-
gous tissue has been used in the reconstruction of the SVC
for other mediastinal malignancies [18,19]. In the field of
cardiovascular surgery, these autologous tissues are prefer-
ably used as conduits, because of their low thrombogenic-
ity, although the long-term patency of these materials in
such patients is still unknown. We believe their long-term
patency to be superior if tumor recurrence does not occur.
Endovascular therapy (EVT) may be primarily preferred as
an initial treatment for SVC syndrome, because of the less
invasiveness. Rizvi et al. concluded that EVT showed sig-
nificant efficacy to relief the symptoms from SVC syn-
drome although surgical therapy remains for patients who
are not eligible for EVT [20]. Charokopos et al. performed
secondary EVT due to the thrombosis in a patient who
underwent the SVC reconstruction with an ePTFE graft
[21]. Thus, EVT may be considered useful less invasive
treatment to improve SVC syndrome.
Table 1 summarizes the clinical results in DTC patients
who presented with tumor thrombus in the mediastinum
great veins. Both histological types, FTCs and PTCs, exhib-
ited tumor thrombi and almost half of the patients died of
disease. The patient's age and gender did not appear to
affect clinical outcomes. More recently published review
articles summarize the results of SVC reconstruction in
other benign and malignant diseases. Lanuti et al. con-
cluded that SVC resection and reconstruction were accept-
able in the selected patients with SVC syndrome [22].
Picquet et al. concluded that SVC reconstruction could be
safely performed as an alternative treatment in patients
who did not respond to more conservative therapies [23].
Radiotherapy is effective in the fraction of thyroid carcino-
mas. Therefore, RI therapy and external beam radiother-World Journal of Surgical Oncology 2009, 7:75 http://www.wjso.com/content/7/1/75
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apy (EBRT) are recommended to improve SVC syndrome
when feasible. Hyer et al. reviewed the results from previ-
ous studies and recommended the use of various treat-
ment modalities, such as surgery, RI therapy, and EBRT
[5]. Taib et al. reported two patients who were successfully
treated with thrombectomy followed by RI therapy [6].
Wilford et al. reported that EBRT contributed remarkably
the improvement of SVC syndrome [9]. However, the ele-
vation of serum TSH levels during the preparation period
for RI therapy may adversely affect the growth of the
tumor and may worsen the SVC syndrome. One of our
patients experienced such progression of SVC syndrome
due to elevated TSH during the preparation period. The
preparation was immediately discontinued and this
patient was then referred to our institution and subse-
quently underwent radical resection and SVC reconstruc-
tion using an autologous pericardial patch. After our
surgery, RI treatment could be safely performed.
Conclusion
To our knowledge, the use of autologous tissue has never
been reported for SVC reconstruction in advanced DTCs
patients. This approach might become the treatment of
choice in surgical intervention for SVC syndrome because
of the tolerance against infection and the anti-thrombo-
genicity of these materials compared with artificial grafts.
Herein, we report the successful treatment of two DTC
patients presenting with SVC syndrome.
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